{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:07:42Z","timestamp":1768874862381,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2011,11,26]],"date-time":"2011-11-26T00:00:00Z","timestamp":1322265600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s10557-011-6303-y","type":"journal-article","created":{"date-parts":[[2011,11,24]],"date-time":"2011-11-24T23:49:23Z","timestamp":1322178563000},"page":"19-31","source":"Crossref","is-referenced-by-count":33,"title":["Effects of Tolvaptan on Volume Overload in Japanese Patients with Heart Failure: Results of a Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study"],"prefix":"10.1007","volume":"25","author":[{"name":"for the Tolvaptan Investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masunori","family":"Matsuzaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Hori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetsugu","family":"Asanoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Tsutamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,26]]},"reference":[{"key":"6303_CR1","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0735-1097(03)00309-7","volume":"41","author":"A Nohria","year":"2003","unstructured":"Nohria A, Tsang SW, Fang JC, et al. Clinical assessment identified hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol. 2003;41:1797\u2013804.","journal-title":"J Am Coll Cardiol"},{"key":"6303_CR2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/eurheartj\/ehi176","volume":"26","author":"S Gupta","year":"2005","unstructured":"Gupta S, Neyses L. Diuretic usage in heart failure: a continuing conundrum in 2005. Eur Heart J. 2005;26:644\u20139.","journal-title":"Eur Heart J"},{"key":"6303_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-103-1-1","volume":"103","author":"GS Francis","year":"1985","unstructured":"Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohormonal axis. Ann Intern Med. 1985;103:1\u20136.","journal-title":"Ann Intern Med"},{"key":"6303_CR4","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/01.CIR.0000070422.41439.04","volume":"107","author":"M Gheorghiade","year":"2003","unstructured":"Gheorghiade M, Niazi I, Ouyang J, et al. Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial. Circulation. 2003;107:2690\u20136.","journal-title":"Circulation"},{"key":"6303_CR5","unstructured":"Japanese Circulation Society. Guidelines for the Treatment of Chronic Heart Failure, 2010. Available at: http:\/\/www.j-circ.or.jp\/guideline\/pdf\/JCS2010_matsuzaki_h.pdf . Accessed 13 April 2011."},{"key":"6303_CR6","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1161\/CIRCULATIONAHA.105.167586","volume":"112","author":"SA Hunt","year":"2005","unstructured":"Hunt SA, Abraham WT, Chin MH, et al. ACC\/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154\u2013235.","journal-title":"Circulation"},{"key":"6303_CR7","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","volume":"25","author":"G Mancia","year":"2007","unstructured":"Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105\u201387.","journal-title":"J Hypertens"},{"key":"6303_CR8","first-page":"20","volume-title":"Manual of nephrology","author":"R Schrier","year":"1995","unstructured":"Schrier R. The patient with hyponatremia or hypernatremia. In: Schrier R, editor. Manual of nephrology. 4th ed. Boston: Little, Brown & Co; 1995. p. 20\u201336.","edition":"4"},{"key":"6303_CR9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-012635690-8\/50005-0","volume-title":"Diuretic agents: clinical physiology and pharmacology","author":"M Zeidel","year":"1997","unstructured":"Zeidel M. Special diuretics. In: Seldin D, Giebisch G, editors. Diuretic agents: clinical physiology and pharmacology. San Diego: Academic Press Inc; 1997. p. 113\u201334."},{"key":"6303_CR10","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","volume":"297","author":"M Gheorghiade","year":"2007","unstructured":"Gheorghiade M, Konstam MA, Burnett JC Jr, et al. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA. 2007;297:1332\u201343.","journal-title":"JAMA"},{"key":"6303_CR11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrd2946","volume":"8","author":"JK Ghali","year":"2009","unstructured":"Ghali JK, Hamad B, Yasothan U, Kirkpatrick P. Tolvaptan. Nat Rev Drug Discov. 2009;8:611\u201312.","journal-title":"Nat Rev Drug Discov"},{"key":"6303_CR12","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","volume":"53","author":"SA Hunt","year":"2009","unstructured":"Hunt SA, Abraham WT, Chin MH, et al. 2009 focused updated incorporated into the ACC\/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines Developed in Collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009;53:e1\u2013e90.","journal-title":"J Am Coll Cardiol"},{"key":"6303_CR13","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1388-9842(03)00150-8","volume":"5","author":"K Muller","year":"2003","unstructured":"Muller K, Gamba G, Jaquet F, Hess B. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV\u2014efficacy and quality of life. Eur J Heart Fail. 2003;5:793\u2013801.","journal-title":"Eur J Heart Fail"},{"key":"6303_CR14","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.amjmed.2006.09.012","volume":"119","author":"HH Chen","year":"2006","unstructured":"Chen HH, Schrier RW. Pathophysiology of volume overload in acute heart failure syndromes. Am J Med. 2006;119:S11\u20136.","journal-title":"Am J Med"},{"key":"6303_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-3466.2007.00001.x","volume":"25","author":"T Miyazaki","year":"2007","unstructured":"Miyazaki T, Fujiki H, Yamamura Y, Nakamura S, Mori T. Tolvaptan, an orally active vasopressin V(2)-receptor antagonist\u2014pharmacology and clinical trials. Cardiovasc Drug Rev. 2007;25:1\u201313.","journal-title":"Cardiovasc Drug Rev"},{"key":"6303_CR16","doi-asserted-by":"crossref","first-page":"F273","DOI":"10.1152\/ajprenal.00195.2005","volume":"290","author":"LC Costello-Boerringter","year":"2006","unstructured":"Costello-Boerringter LC, Smith WB, Boerrigter G, et al. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure. Am J Physiol Renal Physiol. 2006;290:F273\u20138.","journal-title":"Am J Physiol Renal Physiol"},{"key":"6303_CR17","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","volume":"297","author":"MA Konstam","year":"2007","unstructured":"Konstam MA, Gheorghiade M, Burnett JC Jr, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007;297:1319\u201331.","journal-title":"JAMA"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-011-6303-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-011-6303-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-011-6303-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T13:28:10Z","timestamp":1559222890000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-011-6303-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,26]]},"references-count":17,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["6303"],"URL":"https:\/\/doi.org\/10.1007\/s10557-011-6303-y","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,26]]}}}